<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Inst Med Trop Sao Paulo</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev. Inst. Med. Trop. Sao Paulo</journal-id>
      <journal-title-group>
        <journal-title>Revista do Instituto de Medicina Tropical de S&#xE3;o Paulo</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-4665</issn>
      <issn pub-type="epub">1678-9946</issn>
      <publisher>
        <publisher-name>Instituto de Medicina Tropical</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24213198</article-id>
      <article-id pub-id-type="pmc">4105093</article-id>
      <article-id pub-id-type="publisher-id">S0036-46652013000600011</article-id>
      <article-id pub-id-type="doi">10.1590/S0036-46652013000600011</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>USEFULNESS OF kDNA PCR IN THE DIAGNOSIS OF VISCERAL
LEISHMANIASIS REACTIVATION IN CO-INFECTED PATIENTS</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Utilidade da kDNA PCR no diagn&#xF3;stico de reativa&#xE7;&#xE3;o de leishmaniose
visceral em pacientes co-infectados sintom&#xE1;ticos</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nicodemo</surname>
            <given-names>Antonio Carlos</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amato</surname>
            <given-names>Valdir Sabbaga</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tuon</surname>
            <given-names>Felipe Francisco</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Souza</surname>
            <given-names>Regina Maia</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okay</surname>
            <given-names>Thelma Suely</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Braz</surname>
            <given-names>L&#xFA;cia Maria Almeida</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <aff id="aff1"><label>1</label> Department of Infectious and Parasitic Diseases, School of Medicine,
University of S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brazil</aff>
        <aff id="aff2"><label>2</label> Laboratory of Parasitology (LIM46), Institute of Tropical Medicine,
University of S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brazil</aff>
        <aff id="aff3"><label>3</label> Division of Infectious Diseases, Clinics Hospital, Federal
University of Paran&#xE1;, Curitiba, Paran&#xE1;, Brazil</aff>
        <aff id="aff4"><label>4</label> Seroepidemiology Laboratory, Institute of Tropical Medicine,
University of S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brazil</aff>
      </contrib-group>
      <author-notes>
        <corresp><bold>Correspondence to:</bold> Antonio Carlos Nicodemo. Phone: +55 11 3214-4251; Fax
+55 11 3259-1318. E-mail: <email>ac_nicodemo@uol.com.br</email></corresp>
        <fn fn-type="conflict">
          <p><bold>Conflicts of interest statement:</bold> The authors have no associations or commercial relationships which might represent
conflicts of interest.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>55</volume>
      <issue>6</issue>
      <fpage>429</fpage>
      <lpage>431</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>4</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>6</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>SUMMARY</title>
          <p id="para1">It is important to develop new methods for diagnosing relapses in the
co-infection of visceral leishmaniasis (VL) and HIV to enable earlier detection
using less invasive methods. We report a case of a co-infected patient who had
relapses after VL treatment, where the qualitative kDNA PCR showed a good
performance. The kDNA PCR seems to be a useful tool for diagnosing VL and may be a
good marker for predicting VL relapses after treatment of co-infected patients
with clinical symptoms of the disease.</p>
        </sec>
      </abstract>
      <trans-abstract xml:lang="pt">
        <sec>
          <title>RESUMO</title>
          <p id="para2">&#xC9; importante a pesquisa de novos m&#xE9;todos laboratoriais para o
diagn&#xF3;stico de recidivas em casos de co-infec&#xE7;&#xE3;o leishmaniose visceral (LV) e
v&#xED;rus da imunodefici&#xEA;ncia humana (HIV), que permitam o diagn&#xF3;stico precoce das
recidivas, utilizando m&#xE9;todos menos invasivos. Descrevemos aqui, o caso de
paciente co-infectada que apresentou recidivas ap&#xF3;s o tratamento da LV e onde a
PCR qualitativa demonstrou bom desempenho. A kDNA PCR parece ser ferramenta &#xFA;til
para o diagn&#xF3;stico de recidivas de LV ap&#xF3;s o tratamento em pacientes co-infectados
com sintomas cl&#xED;nicos da doen&#xE7;a.</p>
        </sec>
      </trans-abstract>
      <kwd-group>
        <kwd>Visceral Leishmaniasis</kwd>
        <kwd>Polymerase Chain Reaction</kwd>
        <kwd>Diagnosis</kwd>
        <kwd>Co-infection Visceral Leishmaniasis-HIV</kwd>
      </kwd-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="0"/>
        <ref-count count="11"/>
        <page-count count="3"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p id="para3">Visceral leishmaniasis(VL) is a vector-borne disease caused by the <italic>L.
donovani</italic> complex (<italic>L. donovani and L. infantum</italic> or its syn.
<italic>L. chagasi</italic>). It currently affects around 12 million individuals in
88 countries, although more than 90% of the global VL cases occur in only six countries,
namely India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<xref rid="B09" ref-type="bibr">
<sup>9</sup>
</xref>. In Brazil the disease has expanded following a process of
rural-to-urban-transmission, and this urbanization has paralleled ruralization of the
HIV infection. The VL/HIV co-infection has emerged as a serious disease pattern with a
reduction in therapeutic response and a high relapse rate<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref> . Both pathogens have the same target cell (macrophage), thus worsening the
outcome of both diseases. Therefore, it is essential to improve and make diagnostic
techniques available, including molecular tools, which could replace invasive
techniques.</p>
      <p id="para4">Laboratory diagnosis can be reached by serological techniques, such as
indirect immunofluorescence [IFI], enzyme-linked immunosorbent assay [ELISA], or
immunochromatography [IC]. The diagnosis can also be performed by demonstration of
amastigotes in stained bone marrow aspirate which has a sensitivity of 58%-85% and even
by culture in Novy-MacNeal - Nicolle [NNN]/BHI medium; the latter can additionally
improve sensitivity<xref rid="B10" ref-type="bibr">
<sup>10</sup>
</xref> and molecular tests such as kDNA PCR. Serological tests have limited sensitivity
and, as a general rule, should not be used to exclude the diagnosis of VL in
HIV-infected patients<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>. The microscopic examination requires an invasive procedure and is extremely
subjective and time consuming. Culture has low sensitivity and takes from one to four
weeks to give results. Molecular techniques, such as kDNA PCR, in which preserved
sequences in <italic>Leishmania kinetoplast</italic> mini-circle DNA are amplified, have
shown promise<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<xref rid="B11" ref-type="bibr">
<sup>11</sup>
</xref>. Even when they only allow for diagnosis of the genus, it is possible to
diagnose recurrence early since the molecular method can produce a positive result for
VL/HIV several weeks before the clinical onset of disease<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref> . Consequently, the tests based on DNA detection in peripheral blood (PB) or in
bone marrow (BM) aspirates can provide an important approach to the diagnosis of VL
reactivation in co-infected VL/HIV patients.</p>
    </sec>
    <sec sec-type="methods">
      <title>METHODS</title>
      <sec>
        <title>PCR kDNA Methodology</title>
        <p id="para5">
<bold>DNA extraction:</bold> The DNA from PB and BM samples collected with EDTA
anticoagulant was extracted according to the manufacturer's protocol of the RBC (Real
Biotech Corporation) Genomic DNA Mini Kit and eluded in 25 &#xB5;L of elution buffer (TE).
The quantity and the purity of the DNA in the samples were determined using the
Nanodrop Thermo Scientific 1000 spectrophotometer. The samples were subsequently
stored in a freezer at 20 &#xB0;C for later use.</p>
        <p id="para6">
<bold>The polymerase chain reaction (PCR):</bold> In the PCR reaction, kDNA 20 (5&#x2032;GGG
KAG GGG CGT TCT SCG AA 3&#x2032;) and kDNA 22 (5&#x2032; SSS WCT ATW TTA CAC CAA CC CC3&#x2032;) were used
to target the amplification of the conserved region of kDNA mini circles of
<italic>Leishmania</italic> sp, producing a fragment of 120 base pairs<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>. According to the amount of DNA from the extracted material, volumes between
2 and 4 &#xB5;L (100 ng) of sample were added to 20 &#xB5;L of reaction buffer containing 50 mM
of KCl, 10 mM of Tris-HCl (pH 8.0), 0.2 mM of dNTPs, 1.0 mM of MgCl<sub>2</sub>, 0.4
&#xB5;M of each primer and one unit of Taq DNA polymerase (Fermentas, Canada). Two
negative controls were employed containing all of the components of the reaction
together with milli-Q water. The positive control was obtained from the culture
material of the <italic>Leishmania infantum</italic> strain (reference M6445). Each
reaction was performed at an initial denaturation temperature of 94 &#xB0;C for five
minutes followed by 35 cycles of denaturation at 94 &#xB0;C for one minute, annealing at
58 &#xB0;C for one minute, extension at 72 &#xB0;C for 30 seconds, and a final extension of 72
&#xB0;C for five minutes. Reactions were performed in a thermocycler (Mini Cycler MJ
Research/USA). PCR products were visualized on 2% agarose gel. Immediately after
electrophoresis, the gel was stained with 0.5 &#xB5;g/mL of ethidium bromide. The
amplified products were visualized by UV light over a transilluminator (AlphaImager)
(<xref ref-type="fig" rid="f01">Fig. 1</xref>).</p>
        <p>
<fig id="f01" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Detection of kDNA-120 bp amplification in the sample from bone marrow
(BM) and peripheral blood (PB) of the patient with LV.</title></caption><graphic xlink:href="0036-4665-rimtsp-55-06-0429-gf01"/></fig>
</p>
      </sec>
    </sec>
    <sec>
      <title>CASE REPORT AND RESULTS</title>
      <p id="para7">Herein, we report a case of a co-infected (HIV/VL) 32-year-old female, who
was hospitalized six times over a period of one year and a half with clinical suspicion
of VL reactivation.</p>
      <p id="para8">The patient has had the HIV infection since she was 19 years old. The highly
active antiretroviral therapy (HAART) has been used irregularly and the count of CD4+ T
cell never exceeded 100 cells/mm<sup>3</sup>. The first diagnosis of VL was made in
2008.</p>
      <p id="para9">In the patient's first admission to the hospital, she clinically presented
chills, fever, anorexia, and enlargement of liver and spleen. Leishmania was found in
samples from smear examination of BM, and kDNA PCR was positive in the PB. She received
liposomal amphotericin B, 4 mg/kg/day for five days. At this time, the NNN/BHI culture
medium from BM was negative. She was discharged without symptoms.</p>
      <p id="para10">In a second hospitalization, six months later, the patient had fever and
asthenia. Laboratory diagnosis of leishmaniasis was established through PB samples only;
evaluation of smear and culture yielded negative results, but PCR turned out positive,
allowing the patient to receive the same treatment as on the first admission.</p>
      <p id="para11">The patient was hospitalized a third time five months later due to fever,
prostration, and dyspnea. Once more, using only PB samples, smear microscopy, culture
examination, and kDNA PCR were carried out. Again, only the kDNA PCR yielded positive
results. This led to a diagnosis of reactivation and the patient underwent an additional
treatment.</p>
      <p id="para12">Yet another time, five months later, the patient was hospitalized with
symptoms of headache, fever, liver and spleen enlargement, and pancytopenia. Samples of
BM and PB were obtained to perform microscopic examination of smear, culture, and kDNA
PCR. The smear from PB only suggested the presence of amastigotes; the culture was
negative. Once again, because of the positivity of kDNA, the patient was treated. One
month later, the patient was admitted to the hospital once more, this time due to anemia
and again to pancytopenia. In the culture of BM aspirate, promastigotes were observed by
microscopy. The microscopic examination of smear after panoptic staining revealed the
presence of amastigotes. Only at this time PCR was not performed. Finally, in the
patient's last hospitalization two months later, positive results were obtained in
samples of both BM and PB using kDNA PCR, and in BM alone using smear. The PB smear only
suggested the presence of amastigotes; cultures were negative. The patient received the
same treatment as before and was well when discharged.</p>
    </sec>
    <sec>
      <title>DISCUSSION AND CONCLUSION</title>
      <p id="para13">Leishmania/HIV co-infection emerges as a serious disease, demanding a fast
diagnostic method for detecting active disease and relapse so as to enable prompt
treatment. The patient herein reported had several predictors of recurrence, such as
CD4+ cell count below 100 cells/mL at the time of the primary diagnosis of VL, failure
to recover the number of CD4+ lymphocytes after the first episode of VL, and previous
episodes of failure<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>. Significantly, the patient was always a poor adherent to antiviral therapy.
However, even patients who use HAART regularly and have a recovery of the CD4+ cell
count and an undetectable viral load ,and who also receive secondary prophylaxis can
suffer VL relapses.</p>
      <p id="para14">Since co-infection favors a poor outcome, amastigotes can be found in
PB<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref> . Hence, it is possible to avoid invasive and painful techniques, such as bone
marrow aspiration, by replacing them with others that use peripheral blood. The kDNA PCR
assay can be a useful technique especially when PB is utilized. In a study comparing PCR
with parasitological and serological techniques, PIARROUX <italic>et al.</italic>
obtained a sensitivity of 82% for PCR<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>. In our report, kDNA PCR investigation produced positive results in all five
molecular diagnoses in the patient's total of six hospitalizations, suggesting the
hypothesis of VL reactivation. Only once was PCR not performed. In three of her six
hospital stays, when both BM and PB were investigated, PCR was always positive. In two
of the six hospitalizations, only PB was examined, and only kDNA PCR was positive.
Amastigotes were observed by microscopic smear examination four times, and in three of
these, the sample was obtained from BM, necessarily using an invasive technique. On the
sixth admission, the NNN/BHI culture medium was positive in a sample proceeding from BM.
Considering these findings and our aim to apply a non-invasive technique for obtaining
samples, in order to avoid unnecessary pain and to prevent time-consuming techniques and
subjective test interpretations, it is a priority to improve molecular tools for
monitoring patients who are liable to VL reactivation, which is usual in HIV/VL
co-infected patients.</p>
      <p id="para15">It is important to emphasize that co-infected patients do not clear
<italic>Leishmania</italic> DNA from peripheral blood nor can they show a rapid
reappearance of <italic>Leishmania</italic> DNA after therapy and these situations can
or cannot be associated with clinical disease.</p>
      <p id="para16">A negative result is strongly indicative of successful control of infection
and efficacy of treatment, whereas a positive PCR result could be indicative only of the
presence of the parasite, but not necessarily of relapse during an asymptomatic
period<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>. Therefore, qualitative PCR testing positive in the absence of clinical symptoms
of the disease is not always related to VL reactivation in co-infected patients.</p>
      <p id="para17">The kDNA PCR seems to be a useful tool for diagnosing VL, and it may be a
good marker for predicting VL relapses after treatment in co-infected patients with
clinical symptoms of the disease.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p>
<bold>Funding</bold>
</p>
        <p>This study was supported by S&#xE3;o Paulo Research Foundation (Funda&#xE7;&#xE3;o de Amparo &#xE0;
Pesquisa do Estado de S&#xE3;o Paulo - FAPESP, Proc. 2010 50304-8).</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alvar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>V&#xE9;lez</surname>
              <given-names>ID</given-names>
            </name>
            <name>
              <surname>Bern</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Herrero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Desjeux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cano</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Leishmaniasis worldwide and global estimates of its
incidence</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>e35671</fpage>
          <pub-id pub-id-type="pmid">22693548</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alvar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aparicio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Aseffa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Den Boer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ca&#xF1;avate</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dedet</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The relationship between leishmaniasis and AIDS: the
second 10 years</article-title>
          <source>Clin Microbiol Rev</source>
          <year>2008</year>
          <volume>21</volume>
          <fpage>334</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">18400800</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cota</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>de Sousa</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Demarqui</surname>
              <given-names>FN</given-names>
            </name>
            <name>
              <surname>Rabello</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The diagnostic accuracy of serologic and molecular
methods for detecting visceral leishmaniasis in HIV infected patients:
meta-analysis</article-title>
          <source>PLoS Negl Trop Dis</source>
          <year>2012</year>
          <volume>6</volume>
          <fpage>e1665</fpage>
          <pub-id pub-id-type="pmid">22666514</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cota</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>de Sousa</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Rabello</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Predictors of visceral leishmaniasis relapse in
HIV-infected patients: a systematic review</article-title>
          <source>PLoS Negl Trop Dis</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>e1153</fpage>
          <pub-id pub-id-type="pmid">21666786</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Degrave</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bozza</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Use of molecular probes and PCR for detection and typing
of <italic>Leishmania</italic> - a mini review</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>1994</year>
          <volume>89</volume>
          <fpage>463</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">7476234</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nasreen</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Hossain</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Mahmud</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PCR-based detection of <italic>Leishmania</italic> DNA
in skin samples of post kala-azar dermal leishmaniasis patients from an endemic
area of Bangladesh</article-title>
          <source>Jpn J Infect Dis</source>
          <year>2012</year>
          <volume>65</volume>
          <fpage>315</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">22814154</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piarroux</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gambarelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dumon</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fontes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dunan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mary</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparison of PCR with direct examination of bone marrow
aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in
immunocompromised patients</article-title>
          <source>J Clin Microbiol</source>
          <year>1994</year>
          <volume>32</volume>
          <fpage>746</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">8195388</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riera</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fisa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ribera</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Carri&#xF3;</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Falc&#xF3;</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>G&#xE1;llego</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Value of culture and nested polymerase chain reaction of
blood in the prediction of relapses in patients co-infected with
<italic>Leishmania</italic> and human immunodeficiency virus</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2005</year>
          <volume>73</volume>
          <fpage>1012</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">16354803</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srivastava</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sweat</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Azizan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vesely</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kyle</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
          <article-title>Real-time PCR to quantify <italic>Leishmania
donovani</italic> in hamsters</article-title>
          <source>J Parasitol</source>
          <year>2013</year>
          <volume>99</volume>
          <fpage>145</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">22924923</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Griensven</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Diro</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Visceral leishmaniasis</article-title>
          <source>Infect Dis Clin North Am</source>
          <year>2012</year>
          <volume>26</volume>
          <fpage>309</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">22632641</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Volpini</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Passos</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Romanha</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>PCR-RFLP to identify <italic>Leishmania</italic>
(<italic>Viannia</italic>) <italic>braziliensis</italic> and
<italic>L.</italic> (<italic>Leishmania</italic>) <italic>amazonensis</italic>
causing American cutaneous leishmaniasis</article-title>
          <source>Acta Trop</source>
          <year>2004</year>
          <volume>90</volume>
          <fpage>31</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">14739020</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
